During cardiopulmonary resuscitation (CPR) in patients with out-of-hospital cardiac arrest, the interruption of manual chest compressions for rescue breathing reduces blood flow and possibly survival. We assessed whether outcomes after continuous compressions with positive-pressure ventilation differed from those after compressions that were interrupted for ventilations at a ratio of 30 compressions to two ventilations.
tandard cardiopulmonary resuscitation (CPR) consists of manual chest compressions to maintain blood flow and positive-pressure ventilation to maintain oxygenation until spontaneous circulation is restored. 1 Chest compressions are interrupted frequently by ventilations given as rescue breathing during the treatment of out-of-hospital cardiac arrest. [2] [3] [4] These interruptions reduce blood flow and potentially reduce the effectiveness of CPR. 5 One strategy to reduce the interruption of compressions is to provide asynchronous positivepressure ventilation while not pausing for ventilations.
The interruption of chest compressions has been associated with decreased survival in animals with cardiac arrest. 6 In nonasphyxial arrest, continuous compressions were as effective as compressions that were interrupted for ventilations of 4 seconds in duration. 5 Also, the use of continuous compressions resulted in significantly better neurologic function than that with compressions that included longer interruptions for ventilations. 6 In contrast, in asphyxial arrest, ventilation improved outcomes. 7 Observational studies involving humans with out-of-hospital cardiac arrest of presumed cardiac cause have suggested that continuous compressions are associated with higher rates of survival than interrupted compressions. 8, 9 We tested whether continuous chest compressions, as compared with chest compressions interrupted for ventilation, during CPR performed by emergency medical service (EMS) providers affected the rate of survival, neurologic function, or the rate of adverse events.
Me thods

Study Design and Oversight
A detailed description of the design of the trial has been published previously. 10 The trial was conducted by the Resuscitation Outcomes Consortium (ROC). This network includes 10 clinical sites in North America that have experience conducting randomized trials involving patients with out-of-hospital cardiac arrest; the network also includes the regional EMS agencies associated with these sites and a central coordinating center in Seattle. [11] [12] [13] Eight ROC sites and 114 EMS agencies participated in this trial (see the Supplementary Appendix, available with the full text of this article at NEJM.org). Applicable institutional review boards approved the conduct of this study; the requirement for informed consent was waived because the study involved research in emergency medicine. Patients or their legally authorized representatives were informed of participation after the event.
The trial was sponsored by the National Heart, Lung, and Blood Institute, the Canadian Institutes of Health Research, and others (see the Supplementary Appendix). The investigators, including two authors who are employees of the National Institutes of Health, designed and conducted the study, analyzed the data, interpreted the results, wrote the manuscript, and made the decision to submit the manuscript for publication. The trial statisticians had full access to all the data in the study and take responsibility for the integrity of the data, the completeness and accuracy of the data and analyses, and the fidelity of this report to the trial protocol, available at NEJM.org.
Patient Population
The trial included adults with non-trauma-related out-of-hospital cardiac arrest who received chest compressions performed by providers from participating EMS agencies who were dispatched to the scene. Patients were excluded if they had an EMS-witnessed arrest, a written advance directive to not resuscitate, a traumatic injury, an asphyxial cause of arrest, uncontrolled bleeding or exsanguination, known pregnancy, or preexisting tracheostomy; were known to be prisoners; had initial CPR performed by a nonparticipating EMS provider; were treated with a mechanical chest-compression device before manual CPR by ROC EMS personnel; had advanced airway management before ROC EMS agency arrival; or had, a priori, opted not to participate in resuscitation research. Some patients were co-enrolled in a trial of antiarrhythmic therapy for recurrent ventricular fibrillation.
14
Study Interventions
The trial used cluster randomization with crossovers. The 114 participating EMS agencies across the eight participating ROC sites were grouped into 47 clusters. Clusters of agencies were randomly assigned, in a 1:1 ratio, to perform continuous chest compressions or interrupted chest compressions during all the out-of-hospital car-diac arrests to which they responded. Twice per year, each cluster was crossed over to the other resuscitation strategy. The pattern of randomized cluster assignments is shown in Figure S1 in the Supplementary Appendix.
The trial required each cluster of EMS agencies to begin by enrolling patients in a run-in phase to demonstrate adherence to the protocol. Once a cluster demonstrated proficiency with the given treatment by meeting prespecified performance and compliance benchmarks as determined by an internal study monitoring committee, they were entered into the active-enrollment phase. Benchmarks included adherence to randomized treatment-group assignment, timeliness and completion of data entry, and availability of CPR-process measures recorded by the monitor-defibrillator. Details of the randomization and run-in procedures are provided in the Supplementary Appendix.
Patients assigned to the group that received continuous chest compressions (intervention group) were to receive continuous chest compressions at a rate of 100 compressions per minute, with asynchronous positive-pressure ventilations delivered at a rate of 10 ventilations per minute. Patients assigned to the group that received interrupted chest compressions (control group) were to receive compressions that were interrupted for ventilations at a ratio of 30 compressions to two ventilations; ventilations were to be given with positive pressure during a pause in compressions of less than 5 seconds in duration. Details of the CPR protocol, airway management, and use of pressors are provided in the Supplementary Appendix text and in Figures S2 and S3 in the Supplementary Appendix. Hospital-based care, including targeted temperature management, was monitored but was not standardized in this trial.
CPR-Process Monitoring
Study sites were required to acquire and report CPR-process data before beginning enrollment and throughout the trial period. Process data were measured by commercially available monitor-defibrillators during attempted resuscitation. Studysite coordinators were instructed to audit these data for accuracy. In addition, an internal study monitoring committee, whose members were unaware of the treatment outcomes, periodically reviewed these data. Their goal was to assess whether prespecified targets for performance were met for measures such as enrollment rate, treatment-adherence rate, and key elements of concurrent care and then to make recommendations regarding steps to be implemented to increase these rates. 10 Details are provided in the Supplementary Appendix.
Outcomes
The primary outcome was the rate of survival to hospital discharge. Secondary outcomes included neurologic function at discharge, which was measured with the use of the modified Rankin scale (scores range from 0, indicating no symptoms, to 6, indicating death, with a score of ≤3 indicating favorable neurologic function) on the basis of review of the clinical record, and adverse events. Hospital-free survival was defined as the number of days alive and permanently out of the hospital during the first 30 days after the cardiac arrest. Other outcomes were collected for descriptive purposes. Detailed descriptions of the study outcomes are provided in the Supplementary Appendix.
Statistical Analysis
We estimated that 23,600 patients (11,800 patients per group) would need to be enrolled for the study to have 90% power to detect a rate of survival to discharge of 8.1% in the control group versus 9.4% in the intervention group, at an overall two-sided alpha level of 0.05. The estimated survival rate in the control group was based on data from the ROC Prehospital Resuscitation Impedance Valve and Early versus Delayed Analysis (ROC PRIMED) trial. 12, 13 The effectiveness population included all the patients who received the randomly assigned treatment during the active-enrollment phase of the study. The safety population included all the patients who received the randomly assigned treatment during either the run-in phase or the active-enrollment phase. The primary test of the null hypothesis used a difference in event rates divided by the estimated robust standard errors that were based on the Huber-White sandwich estimator. 15, 16 The 95% confidence intervals were calculated with adjustment for interim analyses. The comparisons of the treatment groups with respect to the distribution of the secondary outcomes used robust standard errors but were not adjusted for interim analyses. An independent data and safety monitoring board monitored trial n engl j med nejm.org
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T h e ne w e ngl a nd jou r na l o f m e dicine progress and safety with the use of formal stopping boundaries; interim analyses were performed every 6 months. The effect of treatment on the primary and secondary outcomes within subgroups that were defined according to the presence or absence of prognostic factors was examined separately, as detailed in the Supplementary Appendix. Tests for interaction were performed. The effect of treatment was also examined in two per-protocol analyses in per-protocol populations that were defined on the basis of CPR-process data. The first per-protocol analysis used an automated algorithm to define adherence to CPR process (Table  S1 in the Supplementary Appendix), and the second was based on the assessment of CPR-process data by the research coordinator. In addition, multiple hot-deck imputation was used to account for missing vital-status data at discharge. 17 Further details regarding the statistical analyses are provided in the Supplementary Appendix.
R esult s
Enrollment, Randomization, and Characteristics of the Patients
The first EMS agency entered the run-in phase on June 6, 2011. All the study sites stopped enrollment on May 28, 2015, when the maximum expected enrollment was achieved. Of 35,904 patients with out-of-hospital cardiac arrest who were screened, 26,148 were eligible for participation in the trial and were enrolled in the trial during either the run-in phase or the active-enrollment phase (Fig. 1) . The active-enrollment phase included 23,711 patients, of whom 12,653 were assigned to the intervention group and 11,058 to the control group. Data regarding the primary outcome were available for 12,613 patients (99.7%) in the intervention group and for 11,035 (99.8%) in the control group.
The characteristics of the patients before and after the initiation of the randomly assigned treatment, as well as the characteristics of the EMS providers and the hospital treatments, were generally well balanced between the groups, with some small differences that were not considered to be clinically significant (Tables 1 and  2 ). EMS providers achieved small but important intended differences in CPR process (chest-compression fraction, number of pauses in compressions, and pause length) between the treatment groups ( Table 2, The per-protocol population that was determined by application of an automated algorithm to the CPR-process data excluded 6108 patients in the intervention group and 7371 in the control group. In this per-protocol population, the characteristics of the patients and characteristics of the EMS providers after treatment were imbalanced, with significantly higher rates of a shockable rhythm and prehospital intubation in Protected populations included children, pregnant women, and prisoners. CPR denotes cardiopulmonary resuscitation, DNR do not resuscitate, and EMS emergency medical service. 26 the control group than in the intervention group (Table S2 in the Supplementary Appendix).
Primary and Secondary Outcomes
During the active-enrollment phase, 1129 of 12,613 patients (9.0%) in the intervention group (which received continuous chest compression) and 1072 of 11,035 (9.7%) in the control group (which received interrupted chest compressions) survived to hospital discharge (difference with adjustment for cluster and sequential monitoring, −0.7 percentage points; 95% confidence interval [CI], −1.5 to 0.1; P = 0.07) ( * Plus-minus values are means ±SD. The effectiveness population included all the patients who received the randomly assigned treatment during the active-enrollment phase of the study. The intervention group included patients who received continuous chest compressions, and the control group those who received interrupted chest compressions. There were no significant between-group differences at the significance level of 0.05 except for witness status (P = 0.005) and study site (P<0.001). Data on age were missing for 6 patients in the intervention group and 10 in the control group, data on time from dispatch to first EMS arrival were missing for 229 patients in the intervention group and 207 in the control group, and data on time from dispatch to first arrival of advanced life support were missing for 403 patients in the intervention group and 319 in the control group. CPR denotes cardiopulmonary resuscitation, and EMS emergency medical service. † Obvious causes of cardiac arrest included but were not limited to drug poisoning and terminal illness. ‡ The eight study sites are listed in a different order than the order shown in another table, in order to conceal the identity of the sites and protect sensitive data regarding the EMS agencies. (difference, −2.0 percentage points; 95% CI, −3.6 to −0.5; P = 0.01) or admitted to the hospital (difference, −1.3 percentage points; 95% CI, −2.4 to −0.2; P = 0.03). Hospital-free survival was significantly shorter in the intervention group than in the control group (mean difference, −0.2 days; 95% CI, −0.3 to −0.1; P = 0.004).
In the per-protocol population, the survival rate was significantly lower in the intervention group, which included 6529 patients, than in the control group, which included 3678 patients (adjusted difference, −2.0 percentage points; 95% CI, −2.9 to −1.1; P<0.001). After the imputation of missing outcomes (for 40 patients [0.3%] in the intervention group and for 23 [0.2%] in the control group), the overall difference in the survival rate between the treatment groups in the effectiveness population was still not significant. Adjustment for pretreatment confounders attenuated the difference in the survival rate between the treatment groups (difference, −0.3 percentage points; 95% CI, −1.1 to 0.4; P = 0.38).
Additional Analyses
There were a few nominally significant betweengroup differences in the prespecified pretreatment subgroups (Table 4 ). There was nominal heterogeneity of treatment effect that was related to witnessed status (P = 0.05 for interaction), and individual case adherence to performance benchmarks (P = 0.05 for interaction). There was also nominal heterogeneity of treatment effect that was related to the timing of insertion of an advanced airway (P = 0.04 for interaction), but the distribution of such patients was unbalanced between the treatment groups (Table S3 in the Supplementary Appendix). There was no significant relationship between the difference in survival rate between the treatment groups and the incidence of favorable neurologic status in the control group according to clinical site (Fig. S5 in the Supplementary Appendix). There was no significant difference between the two treatment groups in the rates of individual adverse events (Table S4 in the Supplementary Appendix) or in the time to death or awakening (Fig. S6 in the Supplementary Appendix).
Discussion
In this large randomized trial involving adults with out-of-hospital cardiac arrest, a strategy of continuous manual chest compressions with positive-pressure ventilation was not associated with a significantly higher rate of survival to discharge or favorable neurologic function than a strategy of manual chest compressions with interruptions for ventilation performed by EMS providers. The group assigned to receive continuous chest compressions had significantly Data on time between arrival of EMS to start of CPR were missing for 1397 patients in the intervention group and 1089 in the control group, data on the chest-compression fraction were missing for 2612 patients in the intervention group and 2103 in the control group, data on the number of pauses lasting more than 2 sec were missing for 2878 patients in the intervention group and 2249 in the control group, data on the compression rate were missing for 1430 patients in the intervention group and 1261 in the control group, data on the compression depth were missing for 6164 patients in the intervention group and 5734 in the control group, data on pause before shock were missing for 1135 patients in the intervention group and 1209 in the control group, data on pause after shock were missing for 1213 patients in the intervention group and 1262 in the control group, and data on the epinephrine dose were missing for 23 patients in the intervention group and 23 in the control group. ALPS denotes Amiodarone, Lidocaine, or Placebo Study (ClinicalTrials.gov number, NCT01401647), and ED emergency department. † Some EMS agencies were able to report attempted intubation and others successful intubation. The denominators differ owing to missing data. ‡ The chest-compression fraction is the proportion of each minute during which compressions were given. § Values are for patients who received epinephrine. ¶ Values are for patients admitted as in-patients to the hospital. Difference, confidence intervals, and P values for the analysis in the effectiveness population were adjusted for cluster and sequential monitoring; other analyses were adjusted for cluster only. Data on hospital-free survival were missing for 92 patients in the intervention group and 70 in the control group, and data on the modified Rankin scale score were missing for 93 patients in the intervention group and 63 in the control group. ED denotes emergency department. † Hospital-free survival was defined as the number of days alive and permanently out of the hospital during the first 30 days after the cardiac arrest. ‡ Scores on the modified Rankin scale range from 0, indicating no symptoms, to 6, indicating death; a score of 3 or less indicates favorable neurologic function. § The analysis was adjusted for site, age, sex, public location, bystander-witnessed cardiac arrest, bystander-initiated CPR, and time from EMS dispatch to arrival. lower rates of transport to the hospital and admission to the hospital, as well as shorter hospital-free survival, than the group assigned to receive interrupted chest compressions. In the per-protocol analyses, patients who received continuous chest compressions had significantly lower survival rates than those who received compressions with interruptions. Previous observational studies have shown large increases in survival rates among patients with a shockable rhythm 9, [18] [19] [20] with the implementation of continuous compressions by EMS providers versus compressions interrupted for ventilations. Among patients with a noncardiac cause of cardiac arrest who were treated by laypersons 21 or those with a nonshockable rhythm who were treated by EMS providers, 9 continuous compressions were not associated with a significant improvement in outcome. In these previous studies, participating EMS agencies did not measure CPR process when implementing continuous compressions, and implementation occurred simultaneously with other changes, including directions to give intravenous epinephrine early, to use a nonrebreather mask with passive ventilation, to defer airway insertion, and to reduce the number of defibrillations given with each rhythm analysis. In the initial reports of implementation of continuous compressions, 9, 20 most patients received rescue breathing by means of positive-pressure ventilation with a bag-valve mask. Other interventions that each patient received were not reported. It seems plausible that some of the observed improvement in these previous studies was due to improved CPR process (e.g., compression rate and depth), concurrent improvements in the system of care, or Hawthorne effects (changes in behavior resulting from awareness of being observed) 22 rather than to the implementation of continuous compressions alone.
We collected CPR-process data on 90% of all the patients and described the pattern of CPR in each group. Overall, the quality of CPR that was delivered to patients was consistent with contemporary evidence-based practice guidelines. 1, 23 However, the per-protocol analysis, which used an automated algorithm to assess adherence to the CPR process, excluded many trial participants. Often, these exclusions occurred because the automated algorithm could not classify patients as having received either continuous chest compressions or interrupted chest compressions. In a post hoc per-protocol analysis with classification according to assessment by the study coordinator, more patients could be classified, but many patients were still not classified as having received the assigned intervention. These are important limitations of the trial.
In the per-protocol analyses, more patients in the group assigned to receive interrupted compressions than in the group assigned to receive continuous compressions were excluded. There were some between-group imbalances in the characteristics of the patients and treatments. As a consequence, the observation that the survival rate was higher with interrupted chest compressions than with continuous chest compressions was subject to confounding by between-group differences. An adjusted per-protocol analysis corrected for measured differences at baseline but could not correct for unmeasured or post-treatment factors that may have influenced the outcome.
Our study has some other limitations. First, the mean difference in the chest-compression fraction (the proportion of each minute during which compressions were given) between the treatment groups during the trial was small. Differences in chest-compression fraction may be associated with outcome. 3, 4 It is possible that in EMS practice outside the context of a clinical trial a larger difference in chest-compression fraction would have occurred and would have been associated with a larger difference in outcome than was observed in this trial.
Second, there was some imbalance in the number of patients assigned to each group in our trial owing to variation in the amount of time during the first cluster period before crossover, an uneven number of cluster periods, and the suspension of a few EMS agencies by the study monitoring committee. There were also some between-group differences in the characteristics of the patients and in the EMS treatment received. Post hoc adjustment for these differences attenuated the difference in the survival rates between the treatment groups (Table  S3 in the Supplementary Appendix).
Third, the quality of postresuscitation care, including the use of targeted temperature management 24, 25 and early coronary angiography, [25] [26] [27] is associated with outcome after out-of-hospital cardiac arrest. We measured but did not man-
The protect sensitive data regarding the EMS agencies. ‡ The first 3 months of the treatment period was defined as either May through July or November through January; the second 3 months was defined as either August through October or February through April. 
